论文部分内容阅读
目的探讨青春期功能性子宫出血患者采用妈富隆进行治疗的临床疗效。方法将68例青春期功能性子宫出血患者随机分为研究组和对照组,研究组采用妈富隆进行治疗,对照组采用倍美力进行治疗,观察两组患者的控制出血时间、完全止血时间、疗效、不良反应。结果研究组控制出血时间为(19±3)h,完全止血时间为(30±5)h,总有效率为100%,不良反应总发生率为11.8%,研究组显著优于对照组(P<0.05)。结论服用妈富隆治疗青春期功能性子宫出血,止血效果好,疗效显著,值得在临床推广。
Objective To investigate the clinical efficacy of Marvelon in the treatment of adolescent dysfunctional uterine bleeding. Methods 68 cases of adolescent dysfunctional uterine bleeding were randomly divided into study group and control group. The study group was treated with Marvelon, and the control group was treated with betamethasone. The control bleeding time, complete hemostasis time and curative effect ,Adverse reactions. Results In the study group, the bleeding time was (19 ± 3) h, the complete hemostasis time was (30 ± 5) h, the total effective rate was 100% and the total adverse reaction rate was 11.8%. The study group was significantly better than the control group <0.05). Conclusion Marvelon treatment of adolescent dysfunctional uterine bleeding, hemostatic effect is good, the effect is significant, it is worth in the clinical promotion.